Symbols / PVLA Stock $114.24 -3.98% Palvella Therapeutics, Inc.

Healthcare • Biotechnology • United States • NGM
PVLA (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index —
Sector Healthcare
Industry Biotechnology
CEO —
Exch · Country NGM · United States
Market Cap 1.64B
Enterprise Value —
Income —
Sales —
FCF (ttm) —
Book/sh —
Cash/sh —
Employees —
Insider 10d —
IPO —
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout —
P/E —
Forward P/E —
PEG —
P/S —
P/B —
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio —
Current Ratio —
Debt/Eq —
LT Debt/Eq —
EPS (ttm) —
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA —
ROE —
ROIC —
Gross Margin —
Oper. Margin —
Profit Margin —
Shs Outstand —
Shs Float —
Insider Own —
Instit Own —
Short Float —
Short Ratio —
Short Interest —
52W High —
vs 52W High —
52W Low —
vs 52W Low —
Beta —
Impl. Vol. —
Rel Volume —
Avg Volume —
Volume —
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom —
Prev Close $118.97
Price $114.24
Change -3.98%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest PVLA news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
38.60
+173.87%
14.10
+18.75%
11.87
-34.21%
18.04
Research And Development
22.84
+180.22%
8.15
-7.30%
8.79
-36.67%
13.88
Selling General And Administration
15.76
+165.16%
5.94
+93.24%
3.08
-25.99%
4.16
General And Administrative Expense
15.76
+165.16%
5.94
+93.24%
3.08
-25.99%
4.16
Other Gand A
15.76
+165.16%
5.94
+93.24%
3.08
-25.99%
4.16
Total Expenses
38.60
+173.87%
14.10
+18.75%
11.87
-34.21%
18.04
Operating Income
-38.60
-173.87%
-14.10
-18.75%
-11.87
+34.21%
-18.04
Total Operating Income As Reported
-38.60
-173.87%
-14.10
-18.75%
-11.87
+34.21%
-18.04
EBITDA
-35.90
-173.67%
-13.12
-170.18%
18.69
+203.61%
-18.04
Normalized EBITDA
-35.28
-235.86%
-10.51
-114.76%
-4.89
+72.42%
-17.74
EBIT
-35.90
-173.67%
-13.12
-170.18%
18.69
+203.61%
-18.04
Total Unusual Items
-0.61
+76.56%
-2.61
-111.07%
23.58
+7961.00%
-0.30
Total Unusual Items Excluding Goodwill
-0.61
+76.56%
-2.61
-111.07%
23.58
+7961.00%
-0.30
Special Income Charges
—
0.00
-100.00%
23.10
0.00
Other Special Charges
—
—
-23.10
—
Net Income
-41.72
-139.27%
-17.43
-193.27%
18.69
+167.84%
-27.55
Pretax Income
-41.72
-139.27%
-17.43
-193.27%
18.69
+165.40%
-28.58
Net Non Operating Interest Income Expense
-3.23
+12.16%
-3.67
-158.66%
6.26
+160.45%
-10.36
Interest Expense Non Operating
5.82
+34.77%
4.32
0.00
—
Net Interest Income
-3.23
+12.16%
-3.67
-158.66%
6.26
+160.45%
-10.36
Interest Expense
5.82
+34.77%
4.32
0.00
—
Interest Income Non Operating
2.59
+303.43%
0.64
-89.75%
6.26
—
Interest Income
2.59
+303.43%
0.64
-89.75%
6.26
—
Other Income Expense
0.12
-65.77%
0.34
-98.62%
24.30
+14062.64%
-0.17
Other Non Operating Income Expenses
0.73
-75.33%
2.95
+313.90%
0.71
+465.08%
0.13
Gain On Sale Of Security
-0.61
+76.56%
-2.61
-638.35%
0.48
+261.67%
-0.30
Tax Provision
0.00
0.00
0.00
+100.00%
-1.03
Tax Rate For Calcs
0.00
0.00
0.00
-100.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
+100.00%
-0.01
Net Income Including Noncontrolling Interests
-41.72
-139.27%
-17.43
-193.27%
18.69
+167.84%
-27.55
Net Income From Continuing Operation Net Minority Interest
-41.72
-139.27%
-17.43
-193.27%
18.69
+167.84%
-27.55
Net Income From Continuing And Discontinued Operation
-41.72
-139.27%
-17.43
-193.27%
18.69
+167.84%
-27.55
Net Income Continuous Operations
-41.72
-139.27%
-17.43
-193.27%
18.69
+167.84%
-27.55
Normalized Income
-41.10
-177.29%
-14.82
-203.00%
-4.89
+82.06%
-27.26
Net Income Common Stockholders
-41.72
-139.27%
-17.43
-197.32%
17.91
+165.02%
-27.55
Diluted EPS
-3.71
+52.62%
-7.83
-590.44%
1.60
+165.02%
-2.46
Basic EPS
-3.71
+52.62%
-7.83
-590.44%
1.60
+165.02%
-2.46
Basic Average Shares
11.25
+405.46%
2.23
-80.16%
11.22
+0.00%
11.22
Diluted Average Shares
11.25
+405.46%
2.23
-80.16%
11.22
+0.00%
11.22
Diluted NI Availto Com Stockholders
-41.72
-139.27%
-17.43
-197.32%
17.91
+165.02%
-27.55
Preferred Stock Dividends
—
—
0.78
—
Total Other Finance Cost
—
—
-6.26
-160.45%
10.36
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
59.56
-32.50%
88.23
+1068.97%
7.55
-54.32%
16.52
Current Assets
58.99
-33.15%
88.23
+1068.97%
7.55
-54.32%
16.52
Cash Cash Equivalents And Short Term Investments
57.98
-30.65%
83.60
+1037.44%
7.35
-54.21%
16.05
Cash And Cash Equivalents
57.98
-30.65%
83.60
+1037.44%
7.35
-54.21%
16.05
Receivables
0.00
-100.00%
2.34
0.00
—
Accounts Receivable
0.00
-100.00%
0.36
0.00
—
Taxes Receivable
0.00
-100.00%
1.98
0.00
—
Other Current Assets
1.00
-56.23%
2.30
+1059.60%
0.20
-57.96%
0.47
Total Non Current Assets
0.57
0.00
0.00
0.00
Net PPE
0.57
0.00
—
—
Gross PPE
0.57
0.00
—
—
Properties
0.00
0.00
—
—
Buildings And Improvements
0.57
0.00
—
—
Other Properties
0.57
—
—
—
Total Liabilities Net Minority Interest
31.58
+23.21%
25.63
+124.25%
11.43
-71.21%
39.70
Current Liabilities
11.34
-5.77%
12.04
+410.08%
2.36
-59.18%
5.78
Payables And Accrued Expenses
6.33
+9.11%
5.80
+187.60%
2.02
-58.53%
4.86
Payables
4.59
+0.20%
4.59
+389.96%
0.94
-70.58%
3.18
Accounts Payable
4.59
+0.20%
4.59
+389.96%
0.94
-70.58%
3.18
Current Accrued Expenses
1.73
+42.82%
1.21
+12.22%
1.08
-35.71%
1.68
Pensionand Other Post Retirement Benefit Plans Current
1.92
-37.68%
3.07
+1656.00%
0.17
-77.03%
0.76
Current Debt And Capital Lease Obligation
0.20
—
—
—
Current Capital Lease Obligation
0.20
0.00
—
—
Other Current Liabilities
2.90
-8.40%
3.17
+1773.96%
0.17
+6.29%
0.16
Total Non Current Liabilities Net Minority Interest
20.23
+48.89%
13.59
+49.86%
9.07
-73.26%
33.92
Long Term Debt And Capital Lease Obligation
0.43
0.00
—
—
Long Term Capital Lease Obligation
0.43
0.00
—
—
Other Non Current Liabilities
17.76
+48.72%
11.94
+48.27%
8.05
-75.16%
32.42
Preferred Securities Outside Stock Equity
—
—
70.60
+0.00%
70.60
Stockholders Equity
27.98
-55.30%
62.61
+1713.58%
-3.88
+83.26%
-23.17
Common Stock Equity
27.98
-55.30%
62.61
+184.06%
-74.48
+20.57%
-93.78
Capital Stock
0.01
+9.09%
0.01
-99.98%
70.60
+0.00%
70.60
Common Stock
0.01
+9.09%
0.01
0.00
0.00
Preferred Stock
0.00
0.00
-100.00%
70.60
+0.00%
70.60
Share Issued
12.38
+12.43%
11.01
+0.00%
11.01
-1.86%
11.22
Ordinary Shares Number
12.38
+12.43%
11.01
+0.00%
11.01
-1.86%
11.22
Additional Paid In Capital
163.34
+4.48%
156.33
+8498.90%
1.82
+49.63%
1.22
Retained Earnings
-135.45
-44.50%
-93.73
-22.85%
-76.30
+19.68%
-94.99
Gains Losses Not Affecting Retained Earnings
0.08
+2666.67%
0.00
0.00
—
Other Equity Adjustments
0.08
+2666.67%
0.00
—
—
Total Equity Gross Minority Interest
27.98
-55.30%
62.61
+1713.58%
-3.88
+83.26%
-23.17
Total Capitalization
27.98
-55.30%
62.61
+1713.58%
-3.88
+83.26%
-23.17
Working Capital
47.64
-37.47%
76.20
+1368.70%
5.19
-51.70%
10.74
Invested Capital
27.98
-55.30%
62.61
+184.06%
-74.48
+20.57%
-93.78
Total Debt
0.63
0.00
—
—
Capital Lease Obligations
0.63
0.00
—
—
Net Tangible Assets
27.98
-55.30%
62.61
+1713.58%
-3.88
+83.26%
-23.17
Tangible Book Value
27.98
-55.30%
62.61
+184.06%
-74.48
+20.57%
-93.78
Derivative Product Liabilities
2.04
+23.92%
1.65
+62.43%
1.01
-32.35%
1.50
Preferred Stock Equity
—
—
70.60
+0.00%
70.60
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-25.01
-130.68%
-10.84
+20.89%
-13.70
+7.66%
-14.84
Cash Flow From Continuing Operating Activities
-25.01
-130.68%
-10.84
+20.89%
-13.70
+7.66%
-14.84
Net Income From Continuing Operations
-41.72
-139.27%
-17.43
-193.27%
18.69
+167.84%
-27.55
Other Non Cash Items
5.88
+75.73%
3.35
+111.40%
-29.36
-383.32%
10.36
Stock Based Compensation
6.40
+671.20%
0.83
+37.65%
0.60
+41.22%
0.43
Operating Gains Losses
0.61
-76.56%
2.61
+638.35%
-0.48
-261.67%
0.30
Gain Loss On Investment Securities
0.61
-76.56%
2.61
+638.35%
-0.48
-261.67%
0.30
Change In Working Capital
3.82
+2077.20%
-0.19
+93.87%
-3.15
-294.26%
1.62
Change In Receivables
2.49
+225.99%
-1.98
0.00
—
Changes In Account Receivables
0.39
0.00
—
—
Change In Prepaid Assets
1.36
+190.75%
-1.50
-650.55%
0.27
-60.72%
0.69
Change In Payables And Accrued Expense
-0.04
-101.22%
3.29
+196.08%
-3.42
-469.55%
0.93
Change In Accrued Expense
-1.30
-223.81%
1.05
+189.21%
-1.18
-11.67%
-1.05
Change In Payable
1.26
-43.70%
2.24
+199.69%
-2.25
-213.38%
1.98
Change In Account Payable
1.26
-43.70%
2.24
+199.69%
-2.25
-213.38%
1.98
Financing Cash Flow
-0.66
-100.76%
87.09
+1641.78%
5.00
-47.73%
9.57
Cash Flow From Continuing Financing Activities
-0.66
-100.76%
87.09
+1641.78%
5.00
-47.73%
9.57
Net Issuance Payments Of Debt
0.00
-100.00%
78.43
0.00
—
Issuance Of Debt
0.00
-100.00%
78.43
0.00
—
Long Term Debt Issuance
0.00
-100.00%
78.43
0.00
—
Net Long Term Debt Issuance
0.00
-100.00%
78.43
0.00
—
Proceeds From Stock Option Exercised
0.76
0.00
0.00
-100.00%
0.03
Net Other Financing Charges
-1.42
-116.44%
8.65
+73.10%
5.00
—
Changes In Cash
-25.67
-133.66%
76.25
+976.12%
-8.70
-65.02%
-5.27
Effect Of Exchange Rate Changes
0.05
+1433.33%
0.00
0.00
—
Beginning Cash Position
83.60
+1037.44%
7.35
-54.21%
16.05
-24.73%
21.33
End Cash Position
57.98
-30.65%
83.60
+1037.44%
7.35
-54.21%
16.05
Free Cash Flow
-25.01
-130.68%
-10.84
+20.89%
-13.70
+7.66%
-14.84
Issuance Of Capital Stock
—
—
0.00
-100.00%
9.53
Net Preferred Stock Issuance
—
—
0.00
-100.00%
9.53
Preferred Stock Issuance
—
—
0.00
-100.00%
9.53
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category